Brian Fish is the Director of Global Early Pipeline Commercialization at Otsuka, specializing in bringing early-stage assets to market. His expertise covers strategic planning in oncology and nephrology, with career highlights including leading the Olaparib Alliance strategy at Merck and US Immuno-Oncology marketing at Bristol-Myers Squibb. He is an alumnus of Penn State University and The Wharton School.
Based on his attendance at Penn State University, he may follow Nittany Lions collegiate sports. His professional career in the New Jersey and Pennsylvania region also suggests a possible affinity for Philadelphia-based professional sports teams.
He has specific experience managing a major strategic partnership between pharmaceutical companies from his time at Merck.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.